⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNA News
Avidity Biosciences, Inc. Common Stock
Form 8-K
sec.gov
RNA
Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing
prnewswire.com
RNA
Form 8-K/A
sec.gov
RNA
Form 8-K
sec.gov
RNA
Atrium Therapeutics Announces $50 Million Private Placement
prnewswire.com
RNA
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
RNA
Atrium Therapeutics to Participate in Upcoming Investor Conferences
prnewswire.com
RNA
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
RNA
Form 8-K
sec.gov
RNA
BMY
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
prnewswire.com
RNA
BMY